BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
57,62 $ ↑1,19 (2,11%)
2026-06-05
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership3,673 shares
Latest Disclosed Value $ 207,487
Us Bancorp \de\ reports 3.01% decrease in ownership of 0HNC / BioMarin Pharmaceutical Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 3,673 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $204,586 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 3,787 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -3.01% during the quarter. The current value of the position is $211,638 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,673 -114 -3.01 207 -8.00 0.0001
2026-01-30 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,787 -1,738 -31.46 225 -24.75 0.0003
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,525 -529 -8.74 299 -9.94 0.0004
2025-07-24 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,054 -446 -6.86 333 -27.67 0.0004
2025-05-08 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,500 275 4.42 459 12.22 0.0006
2025-02-05 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,225 -1,165 -15.76 409 -21.19 0.0005
2024-10-28 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,390 -4,342 -37.01 519 -46.22 0.0007
2024-08-07 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,732 21 0.18 966 -5.58 0.0013
2024-05-08 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,711 -2,519 -17.70 1,023 -25.51 0.0014
2024-02-09 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,230 -51,646 -78.40 1,372 -66.19 0.0020
2023-11-03 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 65,876 47,007 249.12 4,058 148.20 0.0066
2023-08-10 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,869 -7,787 -29.21 1,636 -36.92 0.0026
2023-05-09 2023-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 26,656 -25 -0.09 2,592 -6.12 0.0044
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 26,681 3,630 15.75 2,761 41.30 0.0049
2022-10-27 2022-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 23,051 -577 -2.44 1,954 -0.15 0.0040
2022-08-01 2022-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 23,628 -5,904 -19.99 1,957 -14.02 0.0038
2022-05-11 2022-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 29,532 1,900 6.88 2,276 -6.76 0.0038
2022-02-11 2021-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 27,632 2,557 10.20 2,441 26.02 0.0038
2021-11-10 2021-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 25,075 -68 -0.27 1,937 -7.63 0.0036
2021-08-05 2021-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 25,143 -2,908 -10.37 2,097 -0.99 0.0039
2021-04-28 2021-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 28,051 -26,517 -48.59 2,118 -55.74 0.0043
2021-02-04 2020-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 54,568 10,462 23.72 4,785 42.58 0.0103
2020-11-10 2020-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 44,106 -999 -2.21 3,356 -39.66 0.0082
2020-08-07 2020-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 45,105 2,150 5.01 5,562 53.27 0.0146
2020-05-13 2020-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 42,955 740 1.75 3,629 1.68 0.0113
2020-02-04 2019-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 42,215 28,487 207.51 3,569 285.84 0.0091
2019-11-08 2019-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 13,728 4,571 49.92 925 17.83 0.0025
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 9,157 -1,040 -10.20 785 -13.26 0.0022
2019-05-08 2019-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,197 96 0.95 905 5.23 0.0026
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,101 -131 -1.28 860 -13.39 0.0028
2018-10-31 2018-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,232 -619 -5.70 993 -2.74 0.0029
2018-08-08 2018-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,851 576 5.61 1,021 22.57 0.0031
2018-05-08 2018-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,275 21 0.20 833 -8.96 0.0026
2018-02-02 2017-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,254 248 2.48 915 -1.72 0.0028
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 10,006 1,972 24.55 931 27.53 0.0030
2017-07-19 2017-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 8,034 198 2.53 730 6.10 0.0024
2017-05-03 2017-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 7,836 -109 -1.37 688 4.56 0.0024
2017-02-08 2016-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 7,945 1,345 20.38 658 7.69 0.0024
2016-11-04 2016-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 6,600 395 6.37 611 26.76 0.0023
2016-08-10 2016-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 6,205 -492 -7.35 482 -12.84 0.0018
2016-05-13 2016-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 6,697 1,022 18.01 553 -7.06 0.0022
2016-02-10 2015-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 5,675 426 8.12 595 7.59 0.0024
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 5,249 634 13.74 553 -12.50 0.0023
2015-08-10 2015-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 4,615 1,296 39.05 632 52.66 0.0024
2015-05-08 2015-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 3,319 772 30.31 414 80.00 0.0016
2015-02-13 2014-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 2,547 600 30.82 230 63.12 0.0009
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 1,947 -644 -24.86 141 -12.96 0.0006
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 2,591 340 15.10 162 5.88 0.0006
2014-05-14 2014-03-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 2,251 207 10.13 153 6.99 0.0006
2014-02-13 2013-12-31 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 2,044 -2,067 -50.28 143 -51.85 0.0006
2013-11-07 2013-09-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 4,111 2,687 188.69 297 275.95 0.0013
2013-08-09 2013-06-30 13F BIOMARIN PHARMACEUTICAL COMMON STOCK 09061G101 1,424 1,424 79 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.